Anaxomics maps have been presented in the cover page of the November issue of Nature Chemical Biology

Home > Business Cases > Discovery of early preclinical safety biomarkers

Discovery of early preclinical safety biomarkers

Anaxomics and Nucro-Technics will develop a joint research project in the field of new safety biomarkers.

The 2 companies have been awarded a Research Grant from the Spanish and Canadian Government, respectively, in order to develop new biomarkers as early indicators of future safety of drugs in development. Nucro-Technics is a leading Pharmaceutical contract support organization based in Toronto, providing advanced services to the biopharma industry.

More information to be published in this section as research evolves.



punto cuadradoPlease, contact us here to request more information.
Anaxomics on LinkedIn